Adamo Pio d'Adamo

Prof. Adamo Pio d'Adamo

University of Trieste, Trieste, Friuli-Venezia Giulia, Italy
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
LSLifeLines Cohort Study
LifeLines Cohort Study
AKAnna Köttgen
Anna Köttgen
CCCARDIoGRAM Consortium
CARDIoGRAM Consortium
DCDIAGRAM Consortium
DIAGRAM Consortium
ICICBP Consortium
ICBP Consortium
CGChristian Gieger
Christian Gieger

23 July 2014 in Nature
Verified
Journal Article
Open access
PDF file
ASAustralian Ovarian Cancer Study
Australian Ovarian Cancer Study
JPJohn R. B. Perry
John R. B. Perry
TNThe Genica Network
The Genica Network
KFk Con Fab
k Con Fab
TSThe LifeLines Cohort Study
The LifeLines Cohort Study
KOKen K. Ong
Ken K. Ong
Here 106 genomic loci associated with age at menarche, a marker of puberty timing in females, are identified; these loci show enrichment for genes involved in nuclear hormone receptor function, body mass index, and rare disorders of puberty, and for genes located in imprinted regions, with parent-of-origin specific effects at several loci. The age at which females first experience menstruation, called menarche, is a heritable trait associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and general mortality. This large-scale genome-wide association study identifies 123 signals at 106 genomic loci associated with age at menarche. New findings include parent-of-origin-specific allelic associations (both maternally and paternally driven) at three imprinted loci and the implication of retinoic acid and GABAB receptor II signalling and lysine-specific histone demethylation. These data bring new insights into the genetic architecture of puberty timing and suggest a model involving thousands of genetic variants. Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality1. Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation2,3, but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P < 5 × 10−8) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and γ-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition.

21 January 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
CPCristian Pattaro
Cristian Pattaro
ATAlexander Teumer
Alexander Teumer
MGMathias Gorski
Mathias Gorski
ACAudrey Y Chu
Audrey Y Chu
MLMan Li
Man Li
CFCaroline S Fox
Caroline S Fox
Reduced glomerular filtration rate defines chronic kidney disease and is associated with cardiovascular and all-cause mortality. We conducted a meta-analysis of genome-wide association studies for estimated glomerular filtration rate (eGFR), combining data across 133,413 individuals with replication in up to 42,166 individuals. We identify 24 new and confirm 29 previously identified loci. Of these 53 loci, 19 associate with eGFR among individuals with diabetes. Using bioinformatics, we show that identified genes at eGFR loci are enriched for expression in kidney tissues and in pathways relevant for kidney development and transmembrane transporter activity, kidney structure, and regulation of glucose metabolism. Chromatin state mapping and DNase I hypersensitivity analyses across adult tissues demonstrate preferential mapping of associated variants to regulatory regions in kidney but not extra-renal tissues. These findings suggest that genetic determinants of eGFR are mediated largely through direct effects within the kidney and highlight important cell types and biological pathways.

6 November 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TPTwinkal C Pansuriya
Twinkal C Pansuriya
RERonald van Eijk
Ronald van Eijk
ADAdamo Pio d'Adamo
Adamo Pio d'Adamo
MRMaayke A J H van Ruler
Maayke A J H van Ruler
Marieke KuijjerMarieke Kuijjer
Marieke Kuijjer
Judith V.M.G. BovéeJudith V.M.G. Bovée
Judith V.M.G. Bovée
Judith Bovée and colleagues report the identification of somatic mosaic mutations in IDH1 and IDH2 in tumors from individuals with Ollier disease and Maffucci syndrome, which are non-hereditary skeletal disorders characterized by multiple enchondromas. Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions). In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors. Fourteen of 16 subjects had identical mutations in separate lesions. Immunohistochemistry to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes. Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.

2 April 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ASAntonella Spinazzola
Antonella Spinazzola
CVCarlo Viscomi
Carlo Viscomi
EFErika Fernández-Vizarra
Erika Fernández-Vizarra
FCFranco Carrara
Franco Carrara
ADAdamo Pio d'Adamo
Adamo Pio d'Adamo
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

11 September 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LSLifeLines Cohort Study
LifeLines Cohort Study
LWLouise V Wain
Louise V Wain
ECEchoGen consortium
EchoGen consortium
ACAortaGen Consortium
AortaGen Consortium
CGCHARGE Consortium Heart Failure Working Group
CHARGE Consortium Heart Failure Working Group
CDCornelia M van Duijn
Cornelia M van Duijn
Paul Elliott, Martin Tobin, Cornelia van Duijn and colleagues report a genome-wide association study for pulse pressure and mean arterial pressure, identifying six new loci influencing these two traits. Numerous genetic loci have been associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans1,2,3. We now report genome-wide association studies of pulse pressure (PP) and mean arterial pressure (MAP). In discovery (N = 74,064) and follow-up studies (N = 48,607), we identified at genome-wide significance (P = 2.7 × 10−8 to P = 2.3 × 10−13) four new PP loci (at 4q12 near CHIC2, 7q22.3 near PIK3CG, 8q24.12 in NOV and 11q24.3 near ADAMTS8), two new MAP loci (3p21.31 in MAP4 and 10q25.3 near ADRB1) and one locus associated with both of these traits (2q24.3 near FIGN) that has also recently been associated with SBP in east Asians. For three of the new PP loci, the estimated effect for SBP was opposite of that for DBP, in contrast to the majority of common SBP- and DBP-associated variants, which show concordant effects on both traits. These findings suggest new genetic pathways underlying blood pressure variation, some of which may differentially influence SBP and DBP.